CytomX Therapeutics Cash from Financing (TTM) Analysis

CytomX Therapeutics Inc (CTMX)

1.63 -0.05 (-2.98%) USD | NASDAQ | Apr 24, 16:00

1.64 +0.01 (+0.61%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	30.23M
September 30, 2023	30.18M
June 30, 2023	0.507M
March 31, 2023	0.641M
December 31, 2022	0.648M
September 30, 2022	1.141M
June 30, 2022	1.245M
March 31, 2022	1.485M
December 31, 2021	110.21M
September 30, 2021	122.55M
June 30, 2021	122.61M
March 31, 2021	123.47M
December 31, 2020	16.89M
September 30, 2020	4.273M
June 30, 2020	4.169M
March 31, 2020	3.319M
December 31, 2019	1.627M

Date	Value
September 30, 2019	1.95M
June 30, 2019	137.46M
March 31, 2019	137.49M
December 31, 2018	139.62M
September 30, 2018	159.98M
June 30, 2018	25.56M
March 31, 2018	25.51M
December 31, 2017	23.80M
September 30, 2017	3.218M
June 30, 2017	2.309M
March 31, 2017	1.851M
December 31, 2016	0.996M
September 30, 2016	83.14M
June 30, 2016	79.71M
March 31, 2016	152.60M
December 31, 2015	153.40M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.507M

Minimum

Jun 2023

137.46M

Maximum

Jun 2019

37.61M

Average

4.169M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks